PH12019501907A1 - Novel viral replication inhibitors - Google Patents

Novel viral replication inhibitors

Info

Publication number
PH12019501907A1
PH12019501907A1 PH12019501907A PH12019501907A PH12019501907A1 PH 12019501907 A1 PH12019501907 A1 PH 12019501907A1 PH 12019501907 A PH12019501907 A PH 12019501907A PH 12019501907 A PH12019501907 A PH 12019501907A PH 12019501907 A1 PH12019501907 A1 PH 12019501907A1
Authority
PH
Philippines
Prior art keywords
novel compounds
infections
medicine
viral replication
replication inhibitors
Prior art date
Application number
PH12019501907A
Inventor
Doroth‚E Bardiot
Gunter Carlens
Kai Dallmeier
Suzanne Kaptein
Michael Mcnaughton
Arnaud Marchand
Johan Neyts
Wim Smets
Mohamed Koukni
Original Assignee
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1116559.4A external-priority patent/GB201116559D0/en
Application filed by Univ Leuven Kath filed Critical Univ Leuven Kath
Publication of PH12019501907A1 publication Critical patent/PH12019501907A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.
PH12019501907A 2011-09-26 2019-08-16 Novel viral replication inhibitors PH12019501907A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161626410P 2011-09-26 2011-09-26
GBGB1116559.4A GB201116559D0 (en) 2011-09-26 2011-09-26 Novel viral replication inhibitors
PCT/EP2012/069007 WO2013045516A1 (en) 2011-09-26 2012-09-26 Viral replication inhibitors

Publications (1)

Publication Number Publication Date
PH12019501907A1 true PH12019501907A1 (en) 2020-09-14

Family

ID=70289884

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019501907A PH12019501907A1 (en) 2011-09-26 2019-08-16 Novel viral replication inhibitors

Country Status (3)

Country Link
NI (1) NI201400025A (en)
PH (1) PH12019501907A1 (en)
ZA (1) ZA201401665B (en)

Also Published As

Publication number Publication date
ZA201401665B (en) 2021-07-28
NI201400025A (en) 2016-02-15

Similar Documents

Publication Publication Date Title
MY182771A (en) Viral replication inhibitors
PH12015502230B1 (en) Novel viral replication inhibitors
EA201791916A1 (en) 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT
UA113956C2 (en) PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
MD20140035A2 (en) Method for treating hepatitis C virus
UA118010C2 (en) INFLUENCES OF INFLUENZA VIRUS REPLICATION
EA201791776A1 (en) SUBSTITUTED CYCLOPHANES FOR USE WHEN TREATING HCV INFECTION
MX2013003634A (en) Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases.
MX2022009352A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus.
MX2016004492A (en) Inhibitors of human immunodeficiency virus replication.
JO3281B1 (en) Benzofuran Compounds for the Treatment of Hepatitis C Virus Infections
BR112013028679A2 (en) hepatitis c virus inhibitors
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
MX363270B (en) Compositions and methods for inhibiting viral polymerase.
EA201590460A1 (en) METHOD AND MEANS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY (+) RNA-CONTAINING VIRUSES
EA201490963A1 (en) NEW HEMINE DERIVATIVES WITH ANTIBACTERIAL AND ANTI-VIRUS ACTIVITY
PH12019501907A1 (en) Novel viral replication inhibitors
EA201990314A1 (en) NEW VIRAL REPLICATION INHIBITORS
NZ615613A (en) Viral inhibitor composition for in vivo therapeutic use
TH152460A (en) Inhibitors of new virus proliferation
TN2013000335A1 (en) Hepatitis c virus inhibitors
TN2013000453A1 (en) Hepatitis c virus inhibitors
UA111703C2 (en) INFLUENCES OF Flu Virus Replication
UA90646C2 (en) treatment OF often RECCURENT chronic herpetic infection caused by herpes virus of simple I and II type
EA201691083A1 (en) INFLUENZA VIRUS REPLICATION INHIBITORS